Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FOMX

Menlo Therapeutics (FOMX) Stock Price, News & Analysis

Menlo Therapeutics logo

About Menlo Therapeutics Stock (NASDAQ:FOMX)

Advanced Chart

Key Stats

Today's Range
$2.99
$2.99
50-Day Range
$2.99
$2.99
52-Week Range
$1.97
$4.84
Volume
N/A
Average Volume
518,350 shs
Market Capitalization
$184.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FOMX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Menlo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FOMX Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
How to Watch Local FOX Stations Without Cable
Michael J. Fox Foundation taps Palo Alto AI firm
See More Headlines

FOMX Stock Analysis - Frequently Asked Questions

Menlo Therapeutics Inc. (NASDAQ:FOMX) announced its quarterly earnings results on Monday, November, 11th. The specialty pharmaceutical company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.07.

Based on aggregate information from My MarketBeat watchlists, some other companies that Menlo Therapeutics investors own include Sorrento Therapeutics (SRNE), Pfizer (PFE), Amarin (AMRN), Bristol Myers Squibb (BMY), Sangamo Therapeutics (SGMO), Anavex Life Sciences (AVXL) and CRISPR Therapeutics (CRSP).

Company Calendar

Last Earnings
11/11/2019
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medicinals & Botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:FOMX
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$74.16 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.60 million
Price / Cash Flow
N/A
Book Value
$1.70 per share
Price / Book
1.76

Miscellaneous

Free Float
N/A
Market Cap
$184.12 million
Optionable
Optionable
Beta
1.66
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:FOMX) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners